236 related articles for article (PubMed ID: 20421143)
41. Radiation treatment interruptions greater than one week and low hemoglobin levels (12 g/dL) are predictors of local regional failure after definitive concurrent chemotherapy and intensity-modulated radiation therapy for squamous cell carcinoma of the head and neck.
McCloskey SA; Jaggernauth W; Rigual NR; Hicks WL; Popat SR; Sullivan M; Mashtare TL; Khan MK; Loree TR; Singh AK
Am J Clin Oncol; 2009 Dec; 32(6):587-91. PubMed ID: 19581794
[TBL] [Abstract][Full Text] [Related]
42. Combined ipsilateral treatment of cervical lymph nodes metastases from an unknown primary.
Dequanter D; Lothaire P; Gastelblum P; Nguyen TH; Lalami Y; Awada A; Andry G
B-ENT; 2008; 4(3):157-61. PubMed ID: 18949962
[TBL] [Abstract][Full Text] [Related]
43. Comparison of IMRT techniques in the radiotherapeutic management of head and neck cancer: is tomotherapy "better" than step-and-shoot IMRT?
Chen AM; Marsano J; Perks J; Farwell G; Luu Q; Donald PJ; Purdy JA
Technol Cancer Res Treat; 2011 Apr; 10(2):171-7. PubMed ID: 21381795
[TBL] [Abstract][Full Text] [Related]
44. Impact of intensity-modulated radiotherapy on health-related quality of life for head and neck cancer patients: matched-pair comparison with conventional radiotherapy.
Graff P; Lapeyre M; Desandes E; Ortholan C; Bensadoun RJ; Alfonsi M; Maingon P; Giraud P; Bourhis J; Marchesi V; Mège A; Peiffert D
Int J Radiat Oncol Biol Phys; 2007 Apr; 67(5):1309-17. PubMed ID: 17289292
[TBL] [Abstract][Full Text] [Related]
45. Correlation between saliva production and quality of life measurements in head and neck cancer patients treated with intensity-modulated radiotherapy.
Scrimger R; Kanji A; Parliament M; Warkentin H; Field C; Jha N; Hanson J
Am J Clin Oncol; 2007 Jun; 30(3):271-7. PubMed ID: 17551304
[TBL] [Abstract][Full Text] [Related]
46. Very late xerostomia, dysphagia, and neck fibrosis after head and neck radiotherapy.
Baudelet M; Van den Steen L; Tomassen P; Bonte K; Deron P; Huvenne W; Rottey S; De Neve W; Sundahl N; Van Nuffelen G; Duprez F
Head Neck; 2019 Oct; 41(10):3594-3603. PubMed ID: 31329343
[TBL] [Abstract][Full Text] [Related]
47. Palliative radiation therapy for head and neck cancer: toward an optimal fractionation scheme.
Chen AM; Vaughan A; Narayan S; Vijayakumar S
Head Neck; 2008 Dec; 30(12):1586-91. PubMed ID: 18798313
[TBL] [Abstract][Full Text] [Related]
48. Outcome with neck dissection after chemoradiation for N3 head-and-neck squamous cell carcinoma.
Igidbashian L; Fortin B; Guertin L; Soulières D; Coulombe G; Belair M; Charpentier D; Tabet JC; Nguyen-Tan PF
Int J Radiat Oncol Biol Phys; 2010 Jun; 77(2):414-20. PubMed ID: 19775825
[TBL] [Abstract][Full Text] [Related]
49. A novel dose constraint to reduce xerostomia in head-and-neck cancer patients treated with intensity-modulated radiotherapy.
Strigari L; Benassi M; Arcangeli G; Bruzzaniti V; Giovinazzo G; Marucci L
Int J Radiat Oncol Biol Phys; 2010 May; 77(1):269-76. PubMed ID: 20100642
[TBL] [Abstract][Full Text] [Related]
50. Intensity-modulated radiotherapy for oropharyngeal squamous cell carcinoma.
Mendenhall WM; Amdur RJ; Morris CG; Kirwan JM; Li JG
Laryngoscope; 2010 Nov; 120(11):2218-22. PubMed ID: 20938964
[TBL] [Abstract][Full Text] [Related]
51. Simultaneous integrated boost intensity-modulated radiotherapy for locally advanced head-and-neck squamous cell carcinomas: II--clinical results.
Lauve A; Morris M; Schmidt-Ullrich R; Wu Q; Mohan R; Abayomi O; Buck D; Holdford D; Dawson K; Dinardo L; Reiter E
Int J Radiat Oncol Biol Phys; 2004 Oct; 60(2):374-87. PubMed ID: 15380569
[TBL] [Abstract][Full Text] [Related]
52. Analysis of salivary flow and dose-volume modeling of complication incidence in patients with head-and-neck cancer receiving intensity-modulated radiotherapy.
Marzi S; Iaccarino G; Pasciuti K; Soriani A; Benassi M; Arcangeli G; Giovinazzo G; Benassi M; Marucci L
Int J Radiat Oncol Biol Phys; 2009 Mar; 73(4):1252-9. PubMed ID: 19251097
[TBL] [Abstract][Full Text] [Related]
53. Xerostomia in long-term survivors of aggressive non-Hodgkin's lymphoma of Waldeyer's ring: a potential role for parotid-sparing techniques?
Chang DT; Amdur RJ; Pacholke H; Mendenhall NP; Morris CG; Byer GA; Olivier KR
Am J Clin Oncol; 2009 Apr; 32(2):145-9. PubMed ID: 19307951
[TBL] [Abstract][Full Text] [Related]
54. Toxicity and compliance of subcutaneous amifostine in patients undergoing postoperative intensity-modulated radiation therapy for head and neck cancer.
Thorstad WL; Chao KS; Haughey B
Semin Oncol; 2004 Dec; 31(6 Suppl 18):8-12. PubMed ID: 15726516
[TBL] [Abstract][Full Text] [Related]
55. Evaluating the role of prophylactic gastrostomy tube placement prior to definitive chemoradiotherapy for head and neck cancer.
Chen AM; Li BQ; Lau DH; Farwell DG; Luu Q; Stuart K; Newman K; Purdy JA; Vijayakumar S
Int J Radiat Oncol Biol Phys; 2010 Nov; 78(4):1026-32. PubMed ID: 20231073
[TBL] [Abstract][Full Text] [Related]
56. Health-related quality-of-life outcomes following IMRT versus conventional radiotherapy for oropharyngeal squamous cell carcinoma.
Yao M; Karnell LH; Funk GF; Lu H; Dornfeld K; Buatti JM
Int J Radiat Oncol Biol Phys; 2007 Dec; 69(5):1354-60. PubMed ID: 17689885
[TBL] [Abstract][Full Text] [Related]
57. [Diagnosis and treatment of 39 patients with cervical lymph node metastases of squamous cell carcinoma of unknown primary origin, referred to Netherlands Cancer Institute/Antoni van Leeuwenhoek Hospital, 1979-98].
Klop WM; Balm AJ; Keus RB; Hilgers FJ; Tan IB
Ned Tijdschr Geneeskd; 2000 Jul; 144(28):1355-60. PubMed ID: 10923158
[TBL] [Abstract][Full Text] [Related]
58. Importance of the initial volume of parotid glands in xerostomia for patients with head and neck cancers treated with IMRT.
Nishimura Y; Nakamatsu K; Shibata T; Kanamori S; Koike R; Okumura M; Suzuki M
Jpn J Clin Oncol; 2005 Jul; 35(7):375-9. PubMed ID: 15976068
[TBL] [Abstract][Full Text] [Related]
59. Three-dimensional conformal radiotherapy for locally advanced (Stage II and worse) head-and-neck cancer: dosimetric and clinical evaluation.
Portaluri M; Fucilli FI; Castagna R; Bambace S; Pili G; Tramacere F; Russo D; Francavilla MC
Int J Radiat Oncol Biol Phys; 2006 Nov; 66(4):1036-43. PubMed ID: 16750321
[TBL] [Abstract][Full Text] [Related]
60. Xerostomia and quality of life after intensity-modulated radiotherapy vs. conventional radiotherapy for early-stage nasopharyngeal carcinoma: initial report on a randomized controlled clinical trial.
Pow EH; Kwong DL; McMillan AS; Wong MC; Sham JS; Leung LH; Leung WK
Int J Radiat Oncol Biol Phys; 2006 Nov; 66(4):981-91. PubMed ID: 17145528
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]